Chandan Healthcare Limited · NSE:CHANDAN
Chandan Healthcare — Q4 FY26 Earnings Presentation
41 slides from Chandan Healthcare's earnings presentation, Jun 22, 2026
Slide 1: Submission of Investor Presentation to NSE
Date: 22.06.2026 To, National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C /1, G Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400051, Maharashtra, India. Trading Symbol: CHANDAN ISIN: INE0B2N01016 Subject: Submission of Investor Presentation for Q4 and FY26 Pursuant to R
Slide 2: Chandan Healthcare Limited Investor Presentation Q4 & FY26
Chandan Healthcare Limited Investor Presentation Q4 & FY26
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the Presentation), which have been prepared by Chandan Healthcare (Chandan, The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not
Slide 4: Management Comments On Q4 & FY26 Financial Performance
Management Comments On Q4 & FY26 Financial Performance Amar Singh Promoter, Chairman and Managing Director We are pleased to conclude FY26 on a strong note with Total Income of ₹280.67 Cr, EBITDA of ₹56.84 Cr and PAT of ₹27.06 Cr. FY26 has been a year of expansion, strategic investments and network
Slide 5: Q4 FY26 Consolidated Key Financials Highlights
Q4 FY26 Consolidated Key Financials Highlights Total Income EBITDA PAT EBITDA % PAT % 77.41 65.07 19.44% 18.41% 14.25 12.65 6.92 6.02 9.25% 8.94% Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 All Amount In ₹ Cr & Margins In % Investor Presentation 4
Slide 6: FY26 Consolidated Key Financials Highlights
FY26 Consolidated Key Financials Highlights Total Income EBITDA PAT EBITDA % PAT % 280.67 56.84 233.06 20.25% 18.62% 43.39 27.06 22.17 9.51% 9.64% FY25 FY26 FY25 FY26 FY25 FY26 All Amount In ₹ Cr & Margins In % Investor Presentation 5
Slide 7: Q4 & FY26 Consolidated Profit & Loss Statement
Q4 & FY26 Consolidated Profit & Loss Statement In ₹ Cr Particulars Q4 FY26 Q4 FY25 Y-O-Y FY26 FY25 Y-O-Y Operating Income 75.58 62.65 276.39 230.12 Other Income 1.82 2.42 4.28 2.94 Total Income 77.41 65.07 18.96% 280.67 233.06 20.43% Raw Material Expenses 34.75 30.41 133.68 107.62 Employee Benefit E
Slide 8: Q4 FY26 Operational Highlights
Q4 FY26 Operational Highlights Aggressive Multi-City Rollout of Exclusive Jeena Sikho Partnership Across India Punjab Entry – Dera Bassi (HiiMS Meerut Expansion – Muradnagar Facility Panchkula) • Commenced diagnostic operations at a 600+ bed • Commenced diagnostic operations at a 100+ bed partner ho
Slide 9: Q4 FY26 Operational Highlights
Q4 FY26 Operational Highlights Building Long-Term Revenue Visibility Through Government PPP Projects Punjab PPP Projects – District Rohtak MRI Project – Government Assam PPP Project – Railway Hospitals Hospital Hospital • PPP projects across district hospitals in • 10-year project at Civil Hospital,
Slide 10: Q4 FY26 Operational Highlights
Q4 FY26 Operational Highlights Enhancing Network Reach Across Metro and Emerging Cities Mumbai – Access to a Large, High- Kolkata – Building Presence in Raipur – Expanding into Emerging Density Patient Market Eastern India Urban Markets • Entry into Maharashtra with launch of • Entry into West Benga
Slide 11: Company Overview
Company Overview Redefining Diagnostics & Pharmacy in North India Investor Presentation 10
Slide 12: Chandan at a Glance
Chandan at a Glance Chandan Healthcare Limited is one of the leading provider of diagnostic and pharmacy services, and a key entity within the Chandan Group. The Company offers a comprehensive suite of NABL/NABH-accredited pathology and radiology solutions across India. Its service portfolio include
Slide 13: Key Facts & Figures
Key Facts & Figures 20+ 20 Lakh Years Of Industry Experience Total Patient Count (FY26) Decision making icon 1900+ 88 Lakh + Team Size Total Test Conducted(FY26) NABH MIS 360 Collection Centres Accreditation For 6 centres 78+ NABL Accreditation Diagnostic For 16 Labs Centres & Labs Presence 62 Citie
Slide 14: Key Events & Achievements
Key Events & Achievements 2025 2018 Listed in Stock Exchange Won Most Innovative 2025 Crossed turnover of Healthcare Service Provider ₹ 200 Cr 2003 Started its first 2022 diagnostic centre in Crossed turnover of 20 ₹ 100 Cr Indra Nagar Lucknow 23 2003 2013 2019 2024 Incorporation of our Started its
Slide 15: Chandan Group Overview
Chandan Group Overview Chandan Group of Companies HOSPITALS DIAGNOSTICS PHARMACY PHAMACEUTICALS Chandan Healthcare Limited Chandan Pharmacy Limited Cendana Pharmaceuticals Chandan Hospital Chandan Super Private Limited Limited Speciality Limited Presence Presence Uttar Pradesh – 19 Cities Uttar Prad
Slide 16: Board Of Directors
Board Of Directors Amar Singh Asmita Singh Vinay Lamba Promoter, Chairman and Managing Director Promoter and Managing Director Non-Executive Director MBBS with 20+ years of experience in the BBA and MBA with 20+ years of marketing Marine Engineer with 10+ years of experience in healthcare industry e
Slide 17: Business Overview
Business Overview Multi-Segment Model Driving Growth Across B2C, B2B & B2G Investor Presentation 16
Slide 18: Chandan's Core Business Verticals
Chandan’s Core Business Verticals Pathology Radiology Pharmacy FY26 Revenue FY26 Revenue FY26 Revenue ₹119.48 Cr ₹36.70 Cr ₹120.22 Cr (43.23%) (13.28%) (43.50%) Investor Presentation 17
Slide 19: Balanced Business Model Across Retail, Government & Institutions
Balanced Business Model Across Retail, Government & Institutions Diversified Revenue Streams Ensure Stability, Scalability, & Reduced Risk. B2C (Retail Diagnostics) B2B (Institutional Clients) B2G (Government PPPs) • Walk-in services across 62+ • 230+ private hospitals & clinics as • Public-Private
Slide 20: Network Architecture & Centre Formats
Network Architecture & Centre Formats Comprehensive Diagnostic Centre (Total 23) Pathology + Advanced Radiology Top Performing Centre • Complete diagnostic solution under one roof • Name – Lucknow, • Offers pathology, MRI, CT, Ultrasound, X-ray and other imaging services Indira Nagar • One-stop diag
Slide 21: Expansive Regional Footprint Across North & Central India
Expansive Regional Footprint Across North & Central India Glimpse Of Chandan’s Diagnostic Centres PUNJAB CHANDIGARH UTTARAKHAND NEW DELHI HARYANA RAJASTHAN ASSAM UTTAR PRADESH BIHAR GUJRAT WEST BENGAL MADHYA PRADESH CHHATTISGARH MAHARASHTRA KARNATAKA ANDHRA PRADESH Investor Presentation 20
Slide 22: Certified By India's Top Accrediting Bodies
Certified By India’s Top Accrediting Bodies Recognized For Quality Care With 6 NABH-Accredited Centres And 16 NABL- Certified Labs. NABH Indira Nagar NABH MKP Chowk NABH Prayagraj NABL Indira Nagar NABL MKP Chowk UK NABL Karachi Khana Investor Presentation 21
Slide 23: Technology-Driven Healthcare at Chandan
Technology-Driven Healthcare at Chandan • 90+ Specialties 100K+ Downloads • 24x7 Access Available On On Play store • One App for All Healthcare Needs IOS • Online Consultations & Home Sample Collection Chandan 24x7 Digital-first platform strengthening customer loyalty & operational efficiency Unifie
Slide 24: Affordable Healthcare, Strengthened Loyalty
Affordable Healthcare, Strengthened Loyalty Chandan Family Loyalty Card An integrated healthcare membership programme offering patients savings, convenience & holistic family coverage. Key Privileges Strategic Impact for Chandan • Up to 70% savings on Preventive Health • Boosts customer loyalty & ch
Slide 25: Pharmacy Segment – Strong Complement To Diagnostics
Pharmacy Segment – Strong Complement To Diagnostics Widespread Retail Network: 45 company-owned outlets across Uttar Pradesh, Uttarakhand, Madhya Pradesh, Chhattisgarh & Delhi Wholesale Distribution Strength: Centralised supply chain with cold-chain compliance ensures uninterrupted medicine availabi
Slide 26: Key Strengths Driving Sustainable Growth
Key Strengths Driving Sustainable Growth Integrated Diagnostic Platform Digital Ecosystem with Strong Adoption Offers 3,500+ pathology and radiology tests 100K+ downloads of Chandan 24x7 App under NABL/NABH-accredited infrastructure offering e-pharmacy, doctor consultations, test bookings, and digit
Slide 27: Expanding Footprint Across India
Expanding Footprint Across India Network Expansion Plan Expansion Highlights • Targeting a network of 100 labs across 17 states over • One District, One Lab: Phased rollout across the next 3 years UP & Uttarakhand in 2 years • Built 235+ franchises this year; targeting 1,000 • High-End Diagnostics:
Slide 28: Future Roadmap: Chandan Healthcare
Future Roadmap: Chandan Healthcare Maintaining Capital Efficiency: Unlocking Future Value: Fund growth primarily through Explore value unlocking internal accruals; raise capital via pharmacy selectively. restructuring once diagnostics achieve scale. Leveraging Technology for Differentiation: Deploy
Slide 29: Industry Overview
Industry Overview Healthcare Demand Rising Across India’s Metro & Tier-2/3 Cities Investor Presentation 28
Slide 30: Indian Healthcare Industry Overview
Indian Healthcare Industry Overview The Indian Healthcare Sector Is Entering Its Golden Decade. The Indian healthcare market is Indian Healthcare Industry Size in projected to grow from approximately (US$ Billion) US$ 367 billion by 2023 to 700 US$ 638 billion by 2025, representing a 638 Public heal
Slide 31: Indian Diagnostics Sector Overview
Indian Diagnostics Sector Overview Market Size & Growth • Diagnostics industry expected to grow from US$13 Billion (FY23) to US$25 Billion (FY28) at a 14% CAGR. Indian Diagnostic Market (US$ Billion) • Growth driven by rising chronic diseases, ageing population, demand for preventive tests, and wide
Slide 32: Financial Overview
Financial Overview Consistent Growth Backed by Scale, Efficiency & Expansion Investor Presentation 31
Slide 33: Financial Highlights
Financial Highlights Year On Year Revenue Growth Fixed Asset Turnover Interest Coverage Return on Equity 20.43% 2.44 Times 8.00 Times 16.70% Year on Year Profit Return on capital Growth Employed Debt to Equity Book Value 22.04% 20.94% 0.31 Times ₹ 69.93 Investor Presentation 32
Slide 34: Key Financial Highlights
Key Financial Highlights (All Amount In ₹ Cr & Margins In %) Total Income EBITDA EBITDA Margin PAT PAT Margin 27.00% 80.00 45 12.00% 280.67 70.00 20.25% 22.00% 40 18.62% 9.64% 9.22% 9.51% 10.00% 233.06 56.84 35 60.00 15.53% 17.00% 30 8.00% 176.59 50.00 27.06 12.00% 43.39 25 40.00 22.17 6.00% 7.00% 2
Slide 35: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement (In ₹ Cr) Particulars FY24 FY25 FY26 Revenues 176.59 230.12 276.39 Other Income 1.22 2.94 4.28 Total Income 177.81 233.06 280.67 Raw Material Expenses 80.85 107.62 133.68 Employee Costs 35.42 38.86 44.20 Other Expenses 33.92 43.19 45.95 Total Expenditure 150.19 1
Slide 36: Consolidated Balance Sheet
Consolidated Balance Sheet (In ₹ Cr) Equities & Liabilities FY24 FY25 FY26 Assets FY24 FY25 FY26 Equity 20.00 24.45 24.45 Non-Current Assets Reserves And Surplus 21.16 98.15 146.54 Fixed assets 48.49 80.45 113.23 Total Equity 41.16 122.60 171.00 Non-Current Investments 3.38 17.32 7.85 Non-Current Li
Slide 37: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (In ₹ Cr) Particulars FY24 FY25 FY26 Cash Flow from Operating Activities 1.12 -2.75 16.17 Cash Flow from Investing Activities -14.83 -62.04 -39.90 Cash Flow from Financing Activities 15.57 67.11 21.10 Net Increase in Cash & Cash Equivalents 1.86 2.31 -2.63 Investor P
Slide 38: Key Ratios
Key Ratios ROE ROCE (In %) EPS Book value (In ₹) 40.00% 92.00% 35.04% 35.00% 82.00% 69.93 30.00% 72.00% 62.00% 21.46% 20.94% 25.00% 50.14 52.00% 47.60% 20.00% 42.00% 15.00% 32.00% 20.58 19.18% 16.70% 10.00% 22.00% 8.14 10.78 10.76 5.00% 12.00% 2.00% 0.00% FY24 FY25 FY26 FY24 FY25 FY26 (In Times) (In
Slide 39: Stock Data
Stock Data As On 22-06-2026 As On 31-03-2026 NSE (CHANDAN | INE0B2N01016) Share Holding Pattern Share Price (₹) 212.75 Market Capitalization (₹ Cr) 520.22 50.45% Promoter & Promoter Group No. of Shares Outstanding 2,44,52,064 Public Face Value (₹) 10.00 49.55% 52-week High-Low (₹) 358.00 – 184.50 Sh
Slide 40: Investment Rationale
Investment Rationale Integrated Diagnostics Chain offering both pathology and radiology services under one roof, driving patient stickiness and cross-selling opportunities. Widespread Presence with operations across 62+ cities in 16 states, enabling deep regional penetration and first-mover advantag
Slide 41: Thank You
Thank You Chandan Healthcare Limited Biotech Park, Kursi Road, Lucknow 226021 U.P. Email: care@chandan.co.in Phone: 08069366666 Website: www.chandandiagnostic.com Kirin Advisors Private Limited 713-B, Lodha Supremus II, Wagle Estate, Thane West – 400 604 E-mail: info@kirinadvisors.com Phone: 022 410